Junger, Claus; Prochaska, Jurgen H.; Gori, Tommaso et al.
Rationale and design of the effects of EMpagliflozin on left ventricular DIAstolic function in diabetes (EmDia) studyJOURNAL OF CARDIOVASCULAR MEDICINE. Bd. 23. H. 3. 2022 S. 191-197
Mavromanoli, Anna C.; Barco, Stefano; Ageno, Walter et al.
Recovery of right ventricular function after intermediate-risk pulmonary embolism: results from the multicentre Pulmonary Embolism International Trial (PEITHO)-2CLINICAL RESEARCH IN CARDIOLOGY. 2022
Mast, Alan E.; Ruf, Wolfram
Regulation of coagulation by tissue factor pathway inhibitor: Implications for hemophilia therapyJOURNAL OF THROMBOSIS AND HAEMOSTASIS. Bd. 20. H. 6. 2022 S. 1290-1300
Wang, Hongjie; Karnati, Srikanth; Madhusudhan, Thati
Regulation of the Homeostatic Unfolded Protein Response in Diabetic NephropathyPHARMACEUTICALS. Bd. 15. H. 4. 2022
van Paridon, Pauline C. S.; Panova-Noeva, Marina; van Oerle, Rene et al.
Relationships between coagulation factors and thrombin generation in a general population with arterial and venous disease backgroundTHROMBOSIS JOURNAL. Bd. 20. H. 1. 2022
Arnold, Natalie; Hermanns, Iris M.; Schulz, Andreas et al.
Renin, aldosterone, the aldosterone-to-renin ratio, and incident hypertension among normotensive subjects from the general populationCARDIOVASCULAR RESEARCH. 2022
Kohls, Natascha; Konstantinides, ?; Lang, Irene Marthe et al.
Risk stratification and risk-adapted management of acute pulmonary embolismWIENER KLINISCHE WOCHENSCHRIFT. 2022
Hess, Connie N.; Szarek, Michael; Anand, Sonia S. et al.
Rivaroxaban and Risk of Venous Thromboembolism in Patients With Symptomatic Peripheral Artery Disease After Lower Extremity RevascularizationJAMA NETWORK OPEN. Bd. 5. H. 6. 2022
Chakrabarty, Sagarika; Bui, Quyen; Badeanlou, Leylla et al.
S1P/S1PR3 signalling axis protects against obesity-induced metabolic dysfunctionADIPOCYTE. Bd. 11. H. 1. 2022 S. 69-83
Valerio, Luca; Baddour, Larry M.
Septic Pulmonary Embolism. A Contemporary ProfileSEMINARS IN THROMBOSIS AND HEMOSTASIS. 2022